MedPath

The prospective study on the safety of metalic markers for radiotherapy of gynecological cancer

Not Applicable
Conditions
Cervical cancer, Endometrial cancer, Vaginal cancer, Vulvar cancer
Registration Number
JPRN-UMIN000023449
Lead Sponsor
Hyogo Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
75
Inclusion Criteria

Not provided

Exclusion Criteria

Coagulation disorder; Severe coexisting disease; Pregnancy, possible pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sever complications within 3 months after the implantation of metalic markers.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath